TrialNature communications2026

Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.

Narek Shaverdian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.